Familial Chylomicronemia Syndrome Early Access Program (EAP)

Familial Chylomicronemia Syndrome Early Access Program (EAP)

If you are a patient looking to enroll in the volanesorsen EAP, or if you have any questions, please speak with your physician.

Physicians looking to enroll patients should email VolanesorsenEAP@akceatx.com, or call 1-833-EAP-VOLA (1-833-327-8652).

For more information about this expanded access protocol, please visit ClinicalTrials.gov (NCT03544060).

The anticipated time to acknowledge receipt of requests for the volanesorsen Early Access Program is one business day.


Akcea Therapeutics has been acquired by Ionis Pharmaceuticals. For continued news and information about Akcea Therapeutics, please visit ionispharma.com. You are being redirected, please wait. If you have not been redirected in 30 seconds, please click the button below.

Go to ionispharma.com